{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:49:20Z","timestamp":1760986160137,"version":"3.37.3"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00467-022-05753-5","type":"journal-article","created":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T10:02:39Z","timestamp":1665655359000},"page":"1547-1557","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hyperuricemia: an unrecognized risk factor for kidney-related sequelae in children with hemolytic uremic syndrome"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4083-2066","authenticated-orcid":false,"given":"Alejandro","family":"Balestracci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7958-4218","authenticated-orcid":false,"given":"Luciana","family":"Meni Battaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-0516","authenticated-orcid":false,"given":"Ismael","family":"Toledo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0028-8249","authenticated-orcid":false,"given":"Laura","family":"Beaudoin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9178-8582","authenticated-orcid":false,"given":"Sandra Mariel","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9033-6952","authenticated-orcid":false,"given":"Nicol\u00e1s Ariel","family":"Grisol\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4087-9561","authenticated-orcid":false,"given":"Ronald J.","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,13]]},"reference":[{"key":"5753_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2147\/IJNRD.S41837","volume":"7","author":"S Grisaru","year":"2014","unstructured":"Grisaru S (2014) Management of hemolytic-uremic syndrome in children. Int J Nephrol Renovasc Dis 7:231\u2013239. https:\/\/doi.org\/10.2147\/IJNRD.S41837","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"5753_CR2","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00467-018-3991-6","volume":"33","author":"LF Alconcher","year":"2018","unstructured":"Alconcher LF, Coccia PA, Suarez ADC, Monteverde ML, Perez Y Guti\u00e9rrez MG, Carlopio PM, Missoni ML, Balestracci A, Principi I, Ram\u00edrez FB, Estrella P, Micelli S, Leroy DC, Quijada NE, Seminara C, Giordano MI, Hidalgo Sol\u00eds SB, Saurit M, Caminitti A, Arias A, Rivas M, Risso P, Liern M (2018) Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome. Pediatr Nephrol 33:1791\u20131798. https:\/\/doi.org\/10.1007\/s00467-018-3991-6","journal-title":"Pediatr Nephrol"},{"key":"5753_CR3","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1007\/s00467-012-2383-6","volume":"28","author":"JM Spinale","year":"2013","unstructured":"Spinale JM, Ruebner RL, Copelovitch L, Kaplan BS (2013) Long-term outcomes of Shiga toxin hemolytic uremic syndrome. Pediatr Nephrol 28:2097\u20132105. https:\/\/doi.org\/10.1007\/s00467-012-2383-6","journal-title":"Pediatr Nephrol"},{"key":"5753_CR4","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1007\/s00467-007-0522-2","volume":"22","author":"CJ Cobe\u00f1as","year":"2007","unstructured":"Cobe\u00f1as CJ, Alconcher LF, Spizzirri AP, Rahman RC (2007) Long-term follow-up of Argentinean patients with hemolytic uremic syndrome who had not undergone dialysis. Pediatr Nephrol 22:1343\u20131347. https:\/\/doi.org\/10.1007\/s00467-007-0522-2","journal-title":"Pediatr Nephrol"},{"key":"5753_CR5","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1159\/000499939","volume":"142","author":"AA Ejaz","year":"2019","unstructured":"Ejaz AA, Johnson RJ, Shimada M, Mohandas R, Alquadan KF, Beaver TM, Lapsia V, Dass B (2019) The role of uric acid in acute kidney injury. Nephron 142:275\u2013283. https:\/\/doi.org\/10.1159\/000499939","journal-title":"Nephron"},{"key":"5753_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/638732","volume":"2014","author":"IY Kim","year":"2014","unstructured":"Kim IY, Lee DW, Lee SB, Kwak IS (2014) The role of uric acid in kidney fibrosis: experimental evidences for the causal relationship. Biomed Res Int 2014:638732. https:\/\/doi.org\/10.1155\/2014\/638732","journal-title":"Biomed Res Int"},{"key":"5753_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1681\/ASN.V641313","volume":"6","author":"ND Vaziri","year":"1995","unstructured":"Vaziri ND, Freel RW, Hatch M (1995) Effect of chronic experimental renal insufficiency on urate metabolism. J Am Soc Nephrol 6:1313\u20131317. https:\/\/doi.org\/10.1681\/ASN.V641313","journal-title":"J Am Soc Nephrol"},{"key":"5753_CR8","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1007\/s00467-020-04713-1","volume":"35","author":"R Hogg","year":"2020","unstructured":"Hogg R (2020) \u201cDisproportionate\u201d hyperuricemia in children with hemolytic uremic syndrome (HUS): should we regard this as a \u201cmedical emergency\u201d? Pediatr Nephrol 35:2205\u20132210. https:\/\/doi.org\/10.1007\/s00467-020-04713-1","journal-title":"Pediatr Nephrol"},{"key":"5753_CR9","doi-asserted-by":"publisher","first-page":"238","DOI":"10.5546\/aap.2021.eng.238","volume":"119","author":"A Balestracci","year":"2021","unstructured":"Balestracci A, Meni Battaglia L, Toledo I, Martin SM, Puyol I, Beaudoin L, Robledo NL (2021) Diagnostic sensitivity of extended renal and hematologic criteria to define hemolytic uremic syndrome. Arch Argent Pediatr 119:238\u2013244. https:\/\/doi.org\/10.5546\/aap.2021.eng.238","journal-title":"Arch Argent Pediatr"},{"issue":"Suppl 3","key":"5753_CR10","first-page":"27","volume":"66","author":"M Rivas","year":"2006","unstructured":"Rivas M, Miliwebsky E, Chinen I, Deza N, Leotta GA (2006) The epidemiology of hemolytic uremic syndrome in Argentina. Diagnosis of the etiologic agent, reservoirs and routes of transmission. Medicina (B Aires) 66(Suppl 3):27\u201332","journal-title":"Medicina (B Aires)"},{"key":"5753_CR11","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.idc.2013.05.010","volume":"27","author":"TK Davis","year":"2013","unstructured":"Davis TK, McKee R, Schnadower D, Tarr PI (2013) Treatment of Shiga toxin-producing Escherichia coli infections. Infect Dis Clin North Am 27:577\u2013597. https:\/\/doi.org\/10.1016\/j.idc.2013.05.010","journal-title":"Infect Dis Clin North Am"},{"key":"5753_CR12","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1182\/blood.v97.10.2998","volume":"97","author":"SC Goldman","year":"2001","unstructured":"Goldman SC, Holcenberg JS, Finklestein JZ, Hutchinson R, Kreissman S, Johnson FL, Tou C, Harvey E, Morris E, Cairo MS (2001) A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood 97:2998\u20133003. https:\/\/doi.org\/10.1182\/blood.v97.10.2998","journal-title":"Blood"},{"key":"5753_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1007\/s00467-018-3979-2","volume":"34","author":"DJ Weaver Jr","year":"2019","unstructured":"Weaver DJ Jr (2019) Uric acid and progression of chronic kidney disease. Pediatr Nephrol 34:801\u2013809. https:\/\/doi.org\/10.1007\/s00467-018-3979-2","journal-title":"Pediatr Nephrol"},{"key":"5753_CR14","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10157-016-1376-3","volume":"21","author":"T Ninchoji","year":"2017","unstructured":"Ninchoji T, Nozu K, Nakanishi K, Horinouchi T, Fujimura J, Yamamura T, Minamikawa S, Ishimori S, Nakanishi K, Yoshikawa N, Morioka I, Kaito H, Iijima K (2017) Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience. Clin Exp Nephrol 21:889\u2013894. https:\/\/doi.org\/10.1007\/s10157-016-1376-3","journal-title":"Clin Exp Nephrol"},{"key":"5753_CR15","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/ped.12245","volume":"56","author":"A Balestracci","year":"2014","unstructured":"Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE (2014) Laboratory predictors of acute dialysis in hemolytic uremic syndrome. Pediatr Int 56:234\u2013239. https:\/\/doi.org\/10.1111\/ped.12245","journal-title":"Pediatr Int"},{"key":"5753_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s00467-014-2918-0","volume":"30","author":"G Ardissino","year":"2015","unstructured":"Ardissino G, Dacc\u00f2 V, Testa S, Civitillo CF, Tel F, Possenti I, Belingheri M, Castorina P, Bolsa-Ghiringhelli N, Tedeschi S, Paglialonga F, Salardi S, Consonni D, Zoia E, Salice P, Chidini G (2015) Hemoconcentration: a major risk factor for neurological involvement in hemolytic uremic syndrome. Pediatr Nephrol 30:345\u2013352. https:\/\/doi.org\/10.1007\/s00467-014-2918-0","journal-title":"Pediatr Nephrol"},{"key":"5753_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.3389\/fped.2018.00220","volume":"6","author":"L Vaterodt","year":"2018","unstructured":"Vaterodt L, Holle J, H\u00fcseman D, M\u00fcller D, Thumfart J (2018) Short- and long-term renal outcome of hemolytic-uremic syndrome in childhood. Front Pediatr 6:220. https:\/\/doi.org\/10.3389\/fped.2018.00220","journal-title":"Front Pediatr"},{"key":"5753_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00467-011-1973-z","volume":"27","author":"RC Rahman","year":"2012","unstructured":"Rahman RC, Cobe\u00f1as CJ, Drut R, Amoreo OR, Ruscasso JD, Spizzirri AP, Suarez Adel C, Zalba JH, Ferrari C, Gatti MC (2012) Hemorrhagic colitis in postdiarrheal hemolytic uremic syndrome: retrospective analysis of 54 children. Pediatr Nephrol 27:229\u2013233. https:\/\/doi.org\/10.1007\/s00467-011-1973-z","journal-title":"Pediatr Nephrol"},{"key":"5753_CR19","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.2215\/CJN.08921209","volume":"5","author":"S Nathanson","year":"2010","unstructured":"Nathanson S, Kwon T, Elmaleh M, Charbit M, Launay EA, Harambat J, Brun M, Ranchin B, Bandin F, Cloarec S, Bourdat-Michel G, Pi\u00e8trement C, Champion G, Ulinski T, Desch\u00eanes G (2010) Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome. Clin J Am Soc Nephrol 5:1218\u20131228. https:\/\/doi.org\/10.2215\/CJN.08921209","journal-title":"Clin J Am Soc Nephrol"},{"key":"5753_CR20","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/0110.1097\/01.PCC.0000149131.72248.E6","volume":"6","author":"B Goldstein","year":"2005","unstructured":"Goldstein B, Giroir B, Randolph A, International Consensus Conference on Pediatric Sepsis (2005) International pediatric sepsis consensus conference definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 6:2\u20138. https:\/\/doi.org\/10.1097\/01.PCC.0000149131.72248.E6","journal-title":"Pediatr Crit Care Med"},{"key":"5753_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1542\/pir.34-2-79","volume":"34","author":"AI Srinath","year":"2013","unstructured":"Srinath AI, Lowe ME (2013) Pediatric pancreatitis. Pediatr Rev 34:79\u201390. https:\/\/doi.org\/10.1542\/pir.34-2-79","journal-title":"Pediatr Rev"},{"key":"5753_CR22","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.2337\/diacare","volume":"28","author":"RS Suri","year":"2005","unstructured":"Suri RS, Clark WF, Barrowman N, Mahon JL, Thiessen-Philbrook HR, Rosas-Arellano MP, Zarnke K, Garland JS, Garg AX (2005) Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis. Diabetes Care 28:2556\u20132562. https:\/\/doi.org\/10.2337\/diacare","journal-title":"Diabetes Care"},{"unstructured":"KDIGO CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 3:1\u2013150. https:\/\/www.kisupplements.org\/article\/S2157-1716(16)30005-3\/fulltext","key":"5753_CR23"},{"key":"5753_CR24","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1007\/s00467-012-2374-7","volume":"28","author":"MG Caletti","year":"2013","unstructured":"Caletti MG, Balestracci A, Missoni M, Vezzani C (2013) Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome. Pediatr Nephrol 28:745\u2013750. https:\/\/doi.org\/10.1007\/s00467-012-2374-7","journal-title":"Pediatr Nephrol"},{"key":"5753_CR25","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1542\/peds.58.2.259","volume":"58","author":"GJ Schwartz","year":"1976","unstructured":"Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259\u2013263","journal-title":"Pediatrics"},{"key":"5753_CR26","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1542\/peds.111.6.1416","volume":"111","author":"RJ Hogg","year":"2003","unstructured":"Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, Balk E, Lau J, Levin A, Kausz AT, Eknoyan G, Levey AS, National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (2003) National Kidney Foundation\u2019s Kidney Disease Outcomes Quality Initiative clinical practice guidelines for chronic kidney disease in children and adolescents: evaluation, classification, and stratification. Pediatrics 111:1416\u20131421. https:\/\/doi.org\/10.1542\/peds.111.6.1416","journal-title":"Pediatrics"},{"key":"5753_CR27","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.rchipe.2015.04.019","volume":"86","author":"CMP Cubillos","year":"2015","unstructured":"Cubillos CMP, Del Salas P, Zambrano PO (2015) Microalbuminuria in pediatric patients diagnosed with hemolytic uremic syndrome. Rev Chil Pediatr 86:92\u201396. https:\/\/doi.org\/10.1016\/j.rchipe.2015.04.019","journal-title":"Rev Chil Pediatr"},{"key":"5753_CR28","doi-asserted-by":"publisher","first-page":"e20171904","DOI":"10.1542\/peds.2017-3035","volume":"140","author":"JT Flynn","year":"2017","unstructured":"Flynn JT, Kaelber DC, Baker-Smith CM,\u00a0Subcommittee on screening and management of high blood pressure in children et al (2017) Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics 140:e20171904. https:\/\/doi.org\/10.1542\/peds.2017-3035","journal-title":"Pediatrics"},{"key":"5753_CR29","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/oxfordjournals.aje.a115101","volume":"129","author":"RM Mickey","year":"1989","unstructured":"Mickey RM, Greenland S (1989) The impact of confounder selection criteria on effect estimation. Am J Epidemiol 129:125\u2013137. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a115101","journal-title":"Am J Epidemiol"},{"key":"5753_CR30","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/0895-4356(96)00025-x","volume":"49","author":"GW Sun","year":"1996","unstructured":"Sun GW, Shook TL, Kay GL (1996) Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 49:907\u2013916. https:\/\/doi.org\/10.1016\/0895-4356(96)00025-x","journal-title":"J Clin Epidemiol"},{"key":"5753_CR31","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/s0022-3476(64)80337-1","volume":"64","author":"C Gianantonio","year":"1964","unstructured":"Gianantonio C, Vitacco M, Mendilaharzu F, Rutty A, Mendilaharzu J (1964) The hemolytic uremic syndrome. J Pediatr 64:478\u2013491. https:\/\/doi.org\/10.1016\/s0022-3476(64)80337-1","journal-title":"J Pediatr"},{"key":"5753_CR32","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1007\/s004670050248","volume":"11","author":"FD Spizzirri","year":"1997","unstructured":"Spizzirri FD, Rahman RC, Bibiloni N, Ruscasso JD, Amoreo OR (1997) Childhood hemolytic uremic syndrome in Argentina: long-term follow-up and prognostic features. Pediatr Nephrol 11:156\u2013160. https:\/\/doi.org\/10.1007\/s004670050248","journal-title":"Pediatr Nephrol"},{"key":"5753_CR33","doi-asserted-by":"publisher","first-page":"3480718","DOI":"10.1155\/2019\/3480718","volume":"2019","author":"M Kubota","year":"2019","unstructured":"Kubota M (2019) Hyperuricemia in children and adolescents: present knowledge and future directions. J Nutr Metab 2019:3480718. https:\/\/doi.org\/10.1155\/2019\/3480718","journal-title":"J Nutr Metab"},{"doi-asserted-by":"crossref","unstructured":"Gruskin AB, Naiman JL, Polinsky MS, Baluarte HJ, Kaiser BA, Perlnan SA, Morgenstern BZ (1984) Dev Nephrol. In: Strauss J (ed) . Springer, Boston, pp 33\u201342","key":"5753_CR34","DOI":"10.1007\/978-1-4613-3822-2_4"},{"key":"5753_CR35","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1159\/000448629","volume":"134","author":"A Koratala","year":"2016","unstructured":"Koratala A, Singhania G, Alquadan KF, Shimada M, Johnson RJ, Ejaz AA (2016) Serum uric acid exhibits inverse relationship with estimated glomerular filtration rate. Nephron 134:231\u2013237. https:\/\/doi.org\/10.1159\/000448629","journal-title":"Nephron"},{"key":"5753_CR36","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/ped.13366","volume":"59","author":"R Kuge","year":"2017","unstructured":"Kuge R, Morikawa Y, Hasegawa Y (2017) Uric acid and dehydration in children with gastroenteritis. Pediatr Int 59:1151\u20131156. https:\/\/doi.org\/10.1111\/ped.13366","journal-title":"Pediatr Int"},{"key":"5753_CR37","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s00467-012-2158-0","volume":"27","author":"A Balestracci","year":"2012","unstructured":"Balestracci A, Martin SM, Toledo I, Alvarado C, Wainsztein RE (2012) Dehydration at admission increased the need for dialysis in hemolytic uremic syndrome children. Pediatr Nephrol 27:1407\u20131410. https:\/\/doi.org\/10.1007\/s00467-012-2158-0","journal-title":"Pediatr Nephrol"},{"doi-asserted-by":"publisher","unstructured":"Ardissino G, Tel F, Possenti I, Testa S, Consonni D, Paglialonga F, Salardi S, Borsa-Ghiringhelli N, Salice P, Tedeschi S, Castorina P, Colombo RM, Arghittu M, Daprai L, Monzani A, Tozzoli R, Brigotti M, Torresani E (2016) Early volume expansion and outcomes of hemolytic uremic syndrome. Pediatrics 137(1). https:\/\/doi.org\/10.1542\/peds.2015-2153","key":"5753_CR38","DOI":"10.1542\/peds.2015-2153"},{"unstructured":"Fahlen MT, Batuman V (2019) Uric acid nephropathy. https:\/\/emedicine.medscape.com\/article\/244255-overview. Accessed 28 July 2022","key":"5753_CR39"},{"key":"5753_CR40","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1093\/ndt\/gft029","volume":"28","author":"RJ Johnson","year":"2013","unstructured":"Johnson RJ, Nakagawa T, Jalal D, S\u00e1nchez-Lozada LG, Kang DH, Ritz E (2013) Uric acid and chronic kidney disease: which is chasing which? Nephrol Dial Transplant 28:2221\u20132228. https:\/\/doi.org\/10.1093\/ndt\/gft029","journal-title":"Nephrol Dial Transplant"},{"key":"5753_CR41","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s00467-021-05092-x","volume":"37","author":"R Hogg","year":"2022","unstructured":"Hogg R (2022) An evaluation of the roles of hematuria and uric acid in defining the prognosis of patients with IgA nephropathy. Pediatr Nephrol 37:947\u2013958. https:\/\/doi.org\/10.1007\/s00467-021-05092-x","journal-title":"Pediatr Nephrol"},{"key":"5753_CR42","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1681\/ASN.2008010080","volume":"19","author":"RP Obermayr","year":"2008","unstructured":"Obermayr RP, Temml C, Gutjahr G, Knechtelsdorfer M, Oberbauer R, Klauser-Braun R (2008) Elevated uric acid increases the risk for kidney disease. J Am Soc Nephrol 19:2407\u20132413. https:\/\/doi.org\/10.1681\/ASN.2008010080","journal-title":"J Am Soc Nephrol"},{"key":"5753_CR43","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1097\/01.asn.0000034910.58454.fd","volume":"13","author":"DH Kang","year":"2002","unstructured":"Kang DH, Nakagawa T, Feng L, Watanabe S, Han L, Mazzali M, Truong L, Harris R, Johnson RJ (2002) A role for uric acid in the progression of renal disease. J Am Soc Nephrol 13:2888\u20132897. https:\/\/doi.org\/10.1097\/01.asn.0000034910.58454.fd","journal-title":"J Am Soc Nephrol"},{"key":"5753_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000045939","volume":"87","author":"I Ohno","year":"2001","unstructured":"Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M (2001) Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 87:333\u2013339. https:\/\/doi.org\/10.1159\/000045939","journal-title":"Nephron"},{"key":"5753_CR45","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.2337\/dc10-0227","volume":"33","author":"LH Ficociello","year":"2010","unstructured":"Ficociello LH, Rosolowsky ET, Niewczas MA, Maselli NJ, Weinberg JM, Aschengrau A, Eckfeldt JH, Stanton RC, Galecki AT, Doria A, Warram JH, Krolewski AS (2010) High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care 33:1337\u20131343. https:\/\/doi.org\/10.2337\/dc10-0227","journal-title":"Diabetes Care"},{"key":"5753_CR46","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1053\/j.ajkd.2015.06.015","volume":"66","author":"KE Rodenbach","year":"2015","unstructured":"Rodenbach KE, Schneider MF, Furth SL, Moxey-Mims MM, Mitsnefes MM, Weaver DJ, Warady BA, Schwartz GJ (2015) Hyperuricemia and progression of CKD in children and adolescents: the chronic kidney disease in children (CKiD) cohort study. Am J Kidney Dis 66:984\u2013992. https:\/\/doi.org\/10.1053\/j.ajkd.2015.06.015","journal-title":"Am J Kidney Dis"},{"key":"5753_CR47","first-page":"207","volume":"30","author":"S O'Regan","year":"1988","unstructured":"O\u2019Regan S, Rousseau E (1988) Hemolytic uremic syndrome: urate nephropathy superimposed on an acute glomerulopathy? An hypothesis. Clin Nephrol 30:207\u2013210","journal-title":"Clin Nephrol"},{"key":"5753_CR48","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1007\/s00467-012-2181-1","volume":"27","author":"A Balestracci","year":"2012","unstructured":"Balestracci A, Martin SM, Toledo I (2012) Hyperuricemia in children with post-diarrheal hemolytic uremic syndrome. Pediatr Nephrol 27:1421\u20131422. https:\/\/doi.org\/10.1007\/s00467-012-2181-1","journal-title":"Pediatr Nephrol"},{"key":"5753_CR49","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00467-011-2047-y","volume":"27","author":"AA Acosta","year":"2012","unstructured":"Acosta AA, Hogg RJ (2012) Rasburicase for hyperuricemia in hemolytic uremic syndrome. Pediatr Nephrol 27:325\u2013329. https:\/\/doi.org\/10.1007\/s00467-011-2047-y","journal-title":"Pediatr Nephrol"},{"key":"5753_CR50","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00467-020-04528-0","volume":"35","author":"A Balestracci","year":"2020","unstructured":"Balestracci A, Meni Battaglia L, Martin SM, Toledo I (2020) Rasburicase in hemolytic uremic syndrome related to Shiga toxin-producing Escherichia coli: a report of nine cases. Pediatr Nephrol 35:1133\u20131137. https:\/\/doi.org\/10.1007\/s00467-020-04528-0","journal-title":"Pediatr Nephrol"},{"key":"5753_CR51","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00467-020-04644-x","volume":"35","author":"MH Cho","year":"2020","unstructured":"Cho MH, Ahn YH, Lim SH, Kim JH, Ha IS, Cheong HI, Kang HG (2020) Rasburicase improves the outcome of acute kidney injury from typical hemolytic uremic syndrome. Pediatr Nephrol 35:2183\u20132189. https:\/\/doi.org\/10.1007\/s00467-020-04644-x","journal-title":"Pediatr Nephrol"},{"key":"5753_CR52","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s00467-018-4131-z","volume":"34","author":"C Monet-Didailler","year":"2019","unstructured":"Monet-Didailler C, Godron-Dubrasquet A, Madden I, Delmas Y, Llanas B, Harambat J (2019) Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort. Pediatr Nephrol 34:657\u2013662. https:\/\/doi.org\/10.1007\/s00467-018-4131-z","journal-title":"Pediatr Nephrol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-022-05753-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-022-05753-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T13:15:36Z","timestamp":1680095736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-022-05753-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,13]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["5753"],"URL":"https:\/\/doi.org\/10.1007\/s00467-022-05753-5","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"type":"print","value":"0931-041X"},{"type":"electronic","value":"1432-198X"}],"subject":[],"published":{"date-parts":[[2022,10,13]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the ethical standards of the institutional research and ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}